Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Photodynamic therapy: new treatment for refractory lymphocytic infiltration of the skin
- Authors
- Park, K. Y.; Kim, H. K.; Li, K.; Kim, B. J.; Seo, S. J.; Kim, M. N.; Hong, C. K.
- Issue Date
- Apr-2012
- Publisher
- WILEY-BLACKWELL
- Citation
- CLINICAL AND EXPERIMENTAL DERMATOLOGY, v.37, no.3, pp 235 - 237
- Pages
- 3
- Journal Title
- CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Volume
- 37
- Number
- 3
- Start Page
- 235
- End Page
- 237
- ISSN
- 0307-6938
1365-2230
- Abstract
- Lymphocytic infiltration of the skin (LIS) is a relatively uncommon skin condition, first described by Jessner and Kanof in 1953. LIS presents mainly on the face, in particular on the cheeks and earlobe, but also on the neck, upper trunk or proximal limbs of middle-aged adults. LIS is often resistant to treatment. Photodynamic therapy (PDT) refers to the process of applying a topical prodrug, such as 5-aminolaevulinic acid (ALA) or methyl 5-aminolaevulinic acid (MAL), followed by irradiation with visible or ultraviolet light. The prodrug is converted by target tissue to photoactive porphyrins, which lead to local tissue destruction when activated by light. We describe a 48-year-old woman with refractory LIS, who was treated with MAL-PDT.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.